GEN

Elegen and Nutcracker Pilot Cell-Free Manufacturing Process for RNA-Based Personalized Cancer Therapeutics

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
Drug Target Review

Automated cell-free protein synthesis platform cuts costs by 95 percent

South Korean researchers have developed an automated, modular cell-free protein synthesis platform that slashes preparation ...
Medical Xpress

Rapid iron flux test could help improve cartilage repair through cell therapy

Researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP), an interdisciplinary research group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in ...
BioProcess International

Integrating Quality by Design Principles into Gene-Therapy CMC Programs: Establishing Manufacturing Control and Comparability

Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...

Critical Resources advances solid-state battery program to full-format pouch cell testing

Critical Resources Ltd (ASX:CRR, FRA:9S70) has advanced its solid-state lithium-ion battery evaluation program into ...